A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
about
Clinical applications of pulmonary delivery of antibioticsBronchiectasis in the Last Five Years: New DevelopmentsDiagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art reviewInhaled Antibiotics for Gram-Negative Respiratory InfectionsTolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis PatientsAerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.Non-cystic fibrosis bronchiectasis: review and recent advances.Non-cystic fibrosis bronchiectasis.Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis.Bronchiectasis--diagnosis and treatmentThe role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.Inhaled therapeutics for prevention and treatment of pneumoniaAerosolised antibiotics: a critical appraisal of their use.Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature.Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.Evaluation effects of nebulized gentamicin in exacerbation of chronic obstructive lung disease.Delivery of antibiotics to the respiratory tract: an update.Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.Emerging drugs for bronchiectasis.Use of inhaled tobramycin in cystic fibrosis.Challenges in the development of new therapies for bronchiectasis.Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use.Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.Bronchiectasis, part 2: Management.The effects of bronchiectasis on asthma exacerbation.Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.
P2860
Q26996053-7686711C-CFC2-4498-89C2-A73484581FECQ28075732-8D1C192A-AAF4-44DB-9C7A-0F106B476979Q28082500-D2D5DA4E-1359-47E6-BDF6-3A31A916D7B1Q28386160-2E20C6EC-7F80-4BE8-B360-101B4BF4BA26Q28550641-2882FB00-D1B1-4AF8-BB5B-2359F05A01FCQ30830192-7E9D6E9D-2C9D-4700-8B5D-EADFBB6C79F1Q33755342-EFD7DBEA-05E5-4BC8-B8F4-75028D1C8CC9Q33901651-A55792FA-B463-4962-854D-9A9088D44BB0Q34167368-B2C2C7A7-B9C4-4B06-BC28-E4089685DB22Q34360714-5845DF75-240F-4D6D-9408-692D420D4C6CQ35426622-2760847A-F43C-4737-8FC4-7E741C6C582FQ35628004-9C81DA78-928C-462D-9FC1-3FFB8041E5CAQ35917015-46B65FCA-9646-4805-8B02-A0F5A5ACB38BQ35925366-F16725F5-945D-463F-9D36-35B958BF122BQ36349691-D2264AF8-C53A-49F4-8303-ACC9D59A6604Q36627996-4D70737C-0F4D-4457-BFE3-A4443A1E6CC4Q36739797-BF6B4519-EAF0-4B38-B00B-C85477131783Q37029217-CB7B4202-B901-4203-A6C0-D30A03277FA5Q37436736-D7107A53-8D8A-4B34-B22F-22D33AFDC3C3Q37564542-82BF4BB7-949D-443C-B44A-3226C75A3E7FQ37760514-206DF129-0B30-419F-B249-81A49709DE01Q37792657-9FE5238F-F126-4A0F-A54A-45E0E0E565E1Q38027233-CD1F64EB-EBEB-46B5-B4B3-F6463B124899Q38332222-D32C8489-74E6-4586-A522-9ECA967DE6B3Q38387657-EE0C898F-73E3-4512-9EAC-66FCF27F3C6BQ38797806-E7AC65E4-E33D-47DF-BBAA-8DCC5DAB8AE8Q38923436-508087C9-CCA4-4DFE-9E30-7328F7708549Q39308123-9B904644-8942-4152-AD37-D62D68826614Q40093203-F2CF497A-B926-4D25-B3B7-633CBA0C17F8Q42945234-C8B7B62C-BF90-4729-B1D1-1595849DB20AQ43048979-C665F66A-21B8-45FD-97BA-129324ED789FQ46140564-C4118793-D82B-486E-AE96-5F4F9F50612F
P2860
A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A pilot study of the safety an ...... ts with severe bronchiectasis.
@ast
A pilot study of the safety an ...... ts with severe bronchiectasis.
@en
type
label
A pilot study of the safety an ...... ts with severe bronchiectasis.
@ast
A pilot study of the safety an ...... ts with severe bronchiectasis.
@en
prefLabel
A pilot study of the safety an ...... ts with severe bronchiectasis.
@ast
A pilot study of the safety an ...... ts with severe bronchiectasis.
@en
P356
P1433
P1476
A pilot study of the safety an ...... ts with severe bronchiectasis.
@en
P2093
Eric Shore
Paul Scheinberg
P304
P356
10.1378/CHEST.127.4.1420
P407
P577
2005-04-01T00:00:00Z